Genetic modifiers of folate, vitamin B-12, and homocysteine status in a cross-sectional study of the Canadian population

American Journal of Clinical Nutrition

Volumn 101, Issue 6, 2015, Pages 1295-1304

  Zinck, John W R ^a,b   De Groh, Margaret ^a   MacFarlane, Amanda J ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

Canadian Health Measures Survey; Folate; Homocysteine; Single nucleotide polymorphisms; Vitamin B 12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLDIALKYLPHOSPHATASE 1; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE 2; CUBILIN; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 2; FOLIC ACID; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; GLYCINE HYDROXYMETHYLTRANSFERASE; HAPTOCORRIN; HOMOCYSTEINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SERINE HYDROXYMETHYLTRANSFERASE 1; TRANSCOBALAMIN 2 RECEPTOR; TRANSCOBALAMIN II; UNCLASSIFIED DRUG; VITAMIN RECEPTOR; BIOLOGICAL MARKER; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CANADIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; BLOOD; CANADA; CASE CONTROL STUDY; CYANOCOBALAMIN DEFICIENCY; FOLIC ACID DEFICIENCY; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HEALTH SURVEY; METABOLISM; MIDDLE AGED; NEURAL TUBE DEFECT; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CANADA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GENOTYPE; GENOTYPING TECHNIQUES; HEALTH SURVEYS; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEURAL TUBE DEFECTS; NUTRITIONAL STATUS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84930442565     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.107219     Document Type: Article

References (56)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
2. Czeizel AE, Dundas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
3. Fox JT, Stover PJ. Folate-mediated one-carbon metabolism. Vitam Horm 2008;79:1-44.
4. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, Scott JM, Mills JL. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009;123:917-23.
5. Aydin M, Gokkusu C, Ozkok E, Tulubas F, Unlucerci Y, Pamukcu B, Ozbek Z, Umman B. Association of genetic variants in methylenetetrahydrofolate reductase and paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease. Mol Cell Biochem 2009;325:199-208.
6. van der Put NMJ, Trijbels FJM, van den Heuvel LP, Blom HJ, Steegers-Theunissen RPM, Eskes TKAB, Mariman ECM, den Heyer M, Frosst P, Rozen R. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
7. Whitehead AS, Gallagher PM, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields SC, Scott JM. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. QJM 1995;88:763-6.
8. Kirke PN, Mills JL, Whitehead AS, Molly A, Scott JM. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996;348:1037-8.
9. Lim U, Peng K, Shane B, Stover PJ, Litonjua AA, Weiss ST, Gaziano JM, Strawderman RL, Raiszadeh F, Selhub J, et al. Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr 2005;135:1989-94.
10. Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J, O'Leary VB, Molloy AM, Conley M, Scott JM, et al. The 19bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may protect against spina bifida risk by increasing gene expression. Am J Med Genet 2007;143A:1174-80.
11. Parle-McDermott A, Pangilinan F, O'Brien KK, Mills JL, Magee AM, Troendle J, Sutton M, Scott JM, Kirke PN, Molloy AM, et al. A common variant in MTHFD1L is associated with neural tube defects and mRNA splicing efficiency. Hum Mutat 2009;30:1650-6.
12. Pangilinan F, Molloy AM, Mills JL, Troendle JF, Parle-McDermott A, Signore C, O'Leary VB, Chines P, Seay JM, Geiler-Samerotte K, et al. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med Genet 2012;13:62.
13. Tremblay M, Wolfson M, Connor GS. Canadian Health Measures Survey: rationale, background and overview. Health Rep 2007;18(Suppl):7-20.
14. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002;71:1207-15.
15. Boyles AL, Billups AV, Deak KL. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 2006;114:1547-52.
16. Franke B, Vermeulen SHHM, Steegers-Theunissen RPM, Coenen MJ, Schigvenaars MMVAP, Scheffer H, den Heiger M, Blom HJ. An association study of 45 folate-related genes in spina bifida: involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res A Clin Mol Teratol 2009;85:216-26.
17. Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jaques P, Selhub J, Hunter DJ. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 2009;18:4677-87.
18. Martinez CA, Northrup H, Lin JI. Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. Am J Obstet Gynecol 2009;201:394.
19. Shaw GM, Lu W, Zhu H. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 2009;10:49.
20. Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras MG. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 2009;84:477-82.
21. Pangilinan F, Mitchell A, VanderMeer J, Molloy AM, Troendle J, Conley M, Kirke PN, Sutton M, Sequeira JM, Quadros EV, et al. Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects. J Med Genet 2010;47:677-85.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
23. Peakall R, Smouse PE. GENALEX 6: genetic analysis in Excel: population genetic software for teaching and research. Mol Ecol Notes 2006;6:288-95.
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
25. Wickham H. ggplot2: elegant graphics for data analysis. New York (NY): Springer; 2009.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289-300.
27. Botto LD, Yang QH. 5,10-Methylenetetrahydrofolate reductase gene variations and congenital anomalies: a huge review. Am J Epidemiol 2000;151:862-77.
28. Chowdhury S, Hobbs CA, MacLeod SL, Cleves MA, Melnyk S, James SJ, Hu P, Erickson SW. Associations between maternal genotypes and metabolites implicated in congenital heart defects. Mol Genet Metab 2012;107:596-604.
29. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, Maneval DR, Quinlivan EP, Li Z, Bailey LB, et al. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr 2011;93:1365-72.
30. Vollset SE, Igland J, Jenab M, Fredriksen A, Meyer K, Eussen S, Gjessing HK, Ueland PM, Pera G, Sala N. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007;16:2416-24.
31. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
32. Godbole K, Gayathri P, Ghule S, Sasirekha BV, Kanitkar-Damle A, Memane N, Suresh S, Sheth J, Chandak GR, Yajnik CS. Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. Birth Defects Res A Clin Mol Teratol 2011;91:848-56.
33. Stover P, Schirch V. Evidence for the accumulation of a stable intermediate in the nonenzymatic hydrolysis of 5,10-methenyltetrahydropteroylglutamate to 5-formyltetrahydropteroylglutamate. Biochemistry 1992;31:2148-55.
34. Komlósi V, Hitre E, Pap É, Adleff V, Réti A, Székely É, Bíró A, Rudnai P, Schoket B, Müller J, Tóth B, Ottó S, Kásler M, Kralovánszky J, Budai B. SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer. BMC Cancer 2010;10:525.
35. Woeller CF, Anderson DD, Szebenyi DM, Stover PJ. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J Biol Chem 2007;282:17623-31.
36. MacFarlane AJ, Liu X, Perry CA, Flodby P, Allen RH, Stabler SP, Stover PJ. Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J Biol Chem 2008;283:25846-53.
37. Tanwar VS, Chand MP, Kumar J, Garg G, Seth S, Karthikeyan G, Sengupta S. Common variant in FUT2 gene is associated with levels of vitamin B(12) in Indian population. Gene 2013;515:224-8.
38. 12 status and its association with Helicobacter pylori infection in alcohol dependent patients. J Nutr Sci Vitaminol (Tokyo) 2004;50:305-8.
39. Azevedo M, Eriksson S, Mendes N, Serpa J, Figueiredo C, Resende LP, Ruvoën-Clouet N, Haas R, Borén T, Le Pendu J, et al. Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol 2008;215:308-16.
40. Chery C, Hehn A, Mrabet N, Oussalah A, Jeannesson E, Besseau C, Alberto JM, Gross I, Josse T, Gérard P, et al. Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant. Biochimie 2013;95:995-1001.
41. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009;113:186-92.
42. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 2002;3:256-66.
43. 12 metabolic genes that reduces the risk of congenital heart disease in Han Chinese populations. PLoS ONE 2014;9:e88332.
44. Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985;5:115-41.
45. Aitken SM, Kirsch JF. Role of active-site residues Thr81, Ser82, Thr85, Gln157, and Tyr158 in yeast cystathionine beta-synthase catalysis and reaction specificity. Biochemistry 2004;43:1963-71.
46. van Meurs JBJ, Pare G, Schwartz SM. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr 2013;98:668-76.
47. Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. Methylation of tRNAAsp by the DNA methyltransferase homolog DNMT2. Science 2006;311:395-8.
48. Paré G, Chasman DI, Parker AN, Zee RY, Mälarstig A, Seedorf U, Collins R, Watkins H, Hamsten A, Miletich JP, et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population. Circ Cardiovasc Genet 2009;2:142-50.
49. MacFarlane AJ, Greene-Finestone LS, Shi Y. Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey. Am J Clin Nutr 2011;94:1079-87.
50. 12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci USA 2007;104:19995-20000.
51. Koc A, Cengiz M, Ozdemir ZC, Celik H. Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia. Pediatr Hematol Oncol 2012;29:345-53.
52. Habib GM, Barrios R, Shi ZZ, Lieberman MW. Four distinct membrane-bound dipeptidase RNAs are differentially expressed and show discordant regulation with gamma-glutamyl transpeptidase. J Biol Chem 1996;271:16273-80.
53. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of Renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000;97:8010-4.
54. Szegedi SS, Castro CC, Koutmos M, Garrow TA. Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase. J Biol Chem 2008;283:8939-45.
55. MacFarlane AJ. Shi YS, Greene-Finestone LS. High dose compared to low dose vitamin B12 supplement use is not associated with higher vitamin B12 status in children, adolescents and older adults. J Nutr 2014;144:915-20.
56. de Bakker PIW, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.